Loading...
Last update:  May 26, 2023
08:28 +1GMT

Allergenic Molecule  Phl p 1Homo sapiens  
Epidemiology from Literature
CohortYearCountryTestSubjectsPositive (%)Bibliography
1.1 - Asymptomatic2014SpainIgE502.00020140625, Armentia A
1.10 - Any allergy symptom, Diagnosed2010BelgiumIgE8620.93020101214, Gadisseur R
1.10 - Any allergy symptom, Diagnosed2010ItalyIgE1640837.94020100301, Scala E
1.11 - Esophagitis, Diagnosed2013NetherlandsIgE7648.70020131020, van Rhijn BD
1.11 - Esophagitis, Diagnosed2014SpainIgE6740.30020140625, Armentia A
1.11 - Esophagitis, Diagnosed2013SwitzerlandIgE3568.57020130605, Simon D
1.2.1 - Asthma, Diagnosed (Adults)2012SwedenIgE9640.63020120528, Patelis A
1.4 - Respiratory Symptoms, Diagnosed2005AustriaIgE1190.900
1.4 - Respiratory Symptoms, Diagnosed2012FranceIgE12943.40020121204, Caimmi D
1.4 - Respiratory Symptoms, Diagnosed2005GermanyIgE13230.300
1.4 - Respiratory Symptoms, Diagnosed2014ItalyIgE2195.20020141114, Costa C
1.4 - Respiratory Symptoms, Diagnosed2013SpainIgE18746.00020131016, Feliu A
1.4 - Respiratory Symptoms, Diagnosed2011SpainIgE6880.90020110509, Rodriguez D
1.4 - Respiratory Symptoms, Diagnosed2008SpainIgE78654.96020081010, Barber D
1.5 - Atopic Dermatitis, Diagnosed2005AustriaIgE1283.300
1.5 - Atopic Dermatitis, Diagnosed2013GermanyIgE14034.29020130111, Ott H
1.5 - Atopic Dermatitis, Diagnosed2009GermanyIgE2065.00020091005, Ott H
1.5 - Atopic Dermatitis, Diagnosed2005GermanyIgE11321.200
1.9 - Pollen Allergy2014Czech RepublicIgE82669.60020140606, Panzner P
1.9 - Pollen Allergy2014SpainIgE5072.00020140625, Armentia A
10.1 - Normal Control2012BelgiumIgE2711.11020110223, De Knop KJ
10.1 - Normal Control2009BelgiumIgE267.69020091121, Ebo DG
3.1.1 - Source Sensitized (SPT)2003ItalyIgE90466.800
3.1.1 - Source Sensitized (SPT)2003ItalyIgE74982.700
3.1.4 - Source Sensitized (SPT, IgE)2001ItalyIgE7793.500
3.2.1 - Source Sensitized (IgE)2003AustriaIgE2596.000
3.2.1 - Source Sensitized (IgE)2005FinlandIgE5768.000
3.2.1 - Source Sensitized (IgE)1998NetherlandsIgE15474.000
3.2.1 - Source Sensitized (IgE)2000Not DefinedIgE30695.800
3.2.1 - Source Sensitized (IgE)2005Russian FederationIgE1242.000
3.2.1 - Source Sensitized (IgE)2003ZimbabweIgE2580.000
4.1.3 - Heterologous Source Sensitized (SPT)2013ItalyIgE1894.44020131031, Bonura A
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2012AustriaIgE5457.40020120310, Twaroch TE
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2009BelgiumIgE2240.91020091121, Ebo DG
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2012ItalyIgE2661.50020120310, Twaroch TE
4.1.5 - Heterologous Source Sensitized (IgE)2009BelgiumIgE2095.00020091121, Ebo DG
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009AustriaIgE3225.00020090211, Constantin C
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009AustriaIgE2245.50020090211, Constantin C
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009BelgiumIgE3781.08020090826, Ebo DG
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2012SpainIgE23329.50020120726, Flores E
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2012SpainIgE5554.50020120726, Pedrosa M
4.1.8 - Heterologous Source Sensitized (SPT, IgE)2012SpainIgE6852.90020120726, Pedrosa M
5.2.1 - Source Exposed (Symptoms, SPT)1996AustriaIgE29100.000
5.2.1 - Source Exposed (Symptoms, SPT)1996CanadaIgE1593.000
5.2.1 - Source Exposed (Symptoms, SPT)1996DenmarkIgE2696.000
5.2.1 - Source Exposed (Symptoms, SPT)1996FranceIgE3895.000
5.2.1 - Source Exposed (Symptoms, SPT)1996JapanIgE2065.000
5.2.1 - Source Exposed (Symptoms, SPT)2014SpainIgE10396.40020141003, Beitia JM
5.2.1 - Source Exposed (Symptoms, SPT)2011SpainIgE4379.10020110713, Cabrera-Freitag P
5.2.1 - Source Exposed (Symptoms, SPT)1996SwedenIgE3586.000
5.2.1 - Source Exposed (Symptoms, SPT)1996SwitzerlandIgE2070.000
5.2.4 - Source Exposed, Adults (Symptoms, IgE)2012Czech RepublicIgE4893.80020120424, Sekerkova A
5.2.5 - Source Exposed, Children (Symptoms, IgE)2012Czech RepublicIgE8290.20020120424, Sekerkova A
5.2.5 - Source Exposed, Children (Symptoms, IgE)2014SpainIgE5595.55020140618, Cases B
5.3.1 - Source Exposed (Symptoms, IgE)1994AustriaIgE3093.000
5.3.1 - Source Exposed (Symptoms, IgE)2012BelgiumIgE9965.66020110223, De Knop KJ
5.3.1 - Source Exposed (Symptoms, IgE)2014GermanyIgE10192.08020140306, Darsow U
5.3.1 - Source Exposed (Symptoms, IgE)2014SwedenIgE3746.00020140127, Konradsen JR
5.3.1 - Source Exposed (Symptoms, IgE)2014SwedenIgE2857.00020140127, Konradsen JR
5.3.1 - Source Exposed (Symptoms, IgE)2006GermanyIgE (IB)7097.10020060602, Petersen A
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2013AustriaIgE49100.00020131014, Bokanovic D
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2013AustriaIgE4998.00020131014, Bokanovic D
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2013AustriaIgE4967.00020131014, Bokanovic D
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2009AustriaIgE1794.00020090211, Constantin C
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2008AustriaIgE8284.10020080314, Westritschnig K
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2000ItalyIgE27692.000
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2008AustriaSPT8292.68020080314, Westritschnig K
6.2 - General Population (Adults)2012SwedenIgE3717.28020120528, Patelis A
Developed by
Panservice